A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN -amplified neuroblastoma

amplification ( ) is a defining feature of high-risk neuroblastoma (NB) and predicts poor prognosis. However, whether genes within or in close proximity to the amplicon also contribute to NB remains poorly understood. Here, we identify that , a transcription factor encoding gene neighboring the locu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science advances 2023-08, Vol.9 (34), p.eadg6693
Hauptverfasser: Zhang, Hai-Feng, Delaidelli, Alberto, Javed, Sumreen, Turgu, Busra, Morrison, Taylor, Hughes, Christopher S, Yang, Xiaqiu, Pachva, Manideep, Lizardo, Michael M, Singh, Gurdeep, Hoffmann, Jennifer, Huang, Yue Zhou, Patel, Khushbu, Shraim, Rawan, Kung, Sonia H Y, Morin, Gregg B, Aparicio, Samuel, Martinez, Daniel, Maris, John M, Bosse, Kristopher R, Williams, Karla C, Sorensen, Poul H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:amplification ( ) is a defining feature of high-risk neuroblastoma (NB) and predicts poor prognosis. However, whether genes within or in close proximity to the amplicon also contribute to NB remains poorly understood. Here, we identify that , a transcription factor encoding gene neighboring the locus, is frequently coexpressed with and promotes cell survival in NB. GREB1 controls gene expression independently of MYCN, among which we uncover myosin 1B ( ) as being highly expressed in NB and, using a chick chorioallantoic membrane (CAM) model, as a crucial regulator of invasion and metastasis. Global secretome and proteome profiling further delineates MYO1B in regulating secretome reprogramming in NB cells, and the cytokine MIF as an important pro-invasive and pro-metastatic mediator of MYO1B activity. Together, we have identified a putative GREB1-MYO1B-MIF axis as an unconventional mechanism promoting aggressive behavior in NB and independently of MYCN.
ISSN:2375-2548
2375-2548
DOI:10.1126/sciadv.adg6693